TGFB1 and neoplasm: Recent studies have demonstrated that the tumor microenvironment dynamically regulates NK cell function; high tumor burden suppresses NK cell proliferation through TGF-β secretion [14], whereas immune or targeted therapies can partially restore their cytotoxicity [15].